The US FDA has approved mosunetuzumab-axgb (Lunsumio VELO) as a subcutaneous formulation for the treatment of adult patients ...

A research team at Oregon Health & Science University has discovered a promising new drug combination that may help people ...

Researchers with UC Davis Health have launched a study they hope will help improve health outcomes of Latinas who may be ...

Angelina Jolie has surprisingly faced a wave of online abuse. Her recent photoshoot for TIME France is now being viewed as an ...

At 47, Todd Leach learned he carries a genetic mutation that significantly raised his risk for a rare stomach cancer. He had ...

Men, breast cancer is a reality, not just a woman's disease. Rare but serious, it often goes undiagnosed due to lack of ...

Cedars Sinai gets 30M to establish a specialized BRCA cancer center focusing on research, diagnosis, and treatment in Los Angeles.

The U.S. Food and Drug Administration has granted regular approval to treatment with Rubraca (rucaparib) for the treatment of ...

A recent article in JAMA Internal Medicine describes a common genetic mutation found in many breast cancer patients who do not have a family history of the | Cancer ...

At the San Antonio Breast Cancer Symposium, investigators from an international consortium reported that knowledge of BRCA1/2 mutation status strongly influenced surgical decision-making in young ...

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

RAD51-based assessment effectively identifies HER2-negative metastatic breast cancer patients likely to respond to olaparib, especially with BRCA1/2 or PALB2 variants. RAD51-low tumors showed a higher ...